JP2010502701A5 - - Google Patents

Download PDF

Info

Publication number
JP2010502701A5
JP2010502701A5 JP2009527359A JP2009527359A JP2010502701A5 JP 2010502701 A5 JP2010502701 A5 JP 2010502701A5 JP 2009527359 A JP2009527359 A JP 2009527359A JP 2009527359 A JP2009527359 A JP 2009527359A JP 2010502701 A5 JP2010502701 A5 JP 2010502701A5
Authority
JP
Japan
Prior art keywords
composition
nsaid
cps
composition according
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009527359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010502701A (ja
Filing date
Publication date
Priority claimed from US11/842,201 external-priority patent/US20080317684A1/en
Application filed filed Critical
Publication of JP2010502701A publication Critical patent/JP2010502701A/ja
Publication of JP2010502701A5 publication Critical patent/JP2010502701A5/ja
Pending legal-status Critical Current

Links

JP2009527359A 2006-09-06 2007-08-28 局所用組成物 Pending JP2010502701A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82464206P 2006-09-06 2006-09-06
US89388807P 2007-03-09 2007-03-09
US11/842,201 US20080317684A1 (en) 2006-09-06 2007-08-21 Topical Compositions
PCT/US2007/018892 WO2008030359A2 (en) 2006-09-06 2007-08-28 Topical compositions

Publications (2)

Publication Number Publication Date
JP2010502701A JP2010502701A (ja) 2010-01-28
JP2010502701A5 true JP2010502701A5 (enExample) 2010-10-14

Family

ID=39157753

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009527359A Pending JP2010502701A (ja) 2006-09-06 2007-08-28 局所用組成物

Country Status (9)

Country Link
US (4) US20080317684A1 (enExample)
EP (1) EP2066313A2 (enExample)
JP (1) JP2010502701A (enExample)
AR (1) AR062653A1 (enExample)
AU (1) AU2007293460A1 (enExample)
BR (1) BRPI0716881A2 (enExample)
CA (1) CA2662434C (enExample)
MX (1) MX2009002485A (enExample)
WO (1) WO2008030359A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
EP2493465B1 (en) 2009-10-26 2014-10-22 Sephoris Pharmaceuticals, LLC Treatment of sunburn using analgesics and antihistamines
CN103237535A (zh) * 2010-06-30 2013-08-07 盖尔德玛公司 具有spf 30的保湿组合物
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
JP5989095B2 (ja) 2011-05-03 2016-09-07 アポニア ラボラトリーズ インコーポレイテッド イブプロフェンの経皮組成物およびその使用方法
US20130047347A1 (en) * 2011-08-24 2013-02-28 Charles Robert Smith Depilatory Method and Kit
EP2664919A1 (fr) * 2012-05-15 2013-11-20 Jean Hilaire Saurat Une méthode pour identifier les ligands du récepteur AhR possédant une activité sebosuppressive thérapeutique
US9717741B2 (en) 2012-10-11 2017-08-01 Anaplasi Pharmaceuticals Llc Method and compositions for treating psoriasis
WO2014151171A1 (en) * 2013-03-15 2014-09-25 The Procter & Gamble Company Personal care compositions
KR102320051B1 (ko) 2013-10-03 2021-10-29 다우 파마슈티컬 사이언시즈, 인코포레이티드 안정화된 에피나코나졸 조성물
CA3052643A1 (en) 2013-11-22 2015-05-28 Bausch Health Ireland Limited Anti-infective methods, compositions, and devices
US20150174254A1 (en) * 2013-12-23 2015-06-25 Mcneil-Ppc, Inc. Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent
US10137085B2 (en) * 2014-03-19 2018-11-27 Nano And Advanced Materials Institute Limited Nanoemulsion for transdermal delivery and method of making the same
EP3226972A4 (en) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US20180369174A1 (en) * 2015-12-16 2018-12-27 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
GB201609968D0 (en) * 2016-06-07 2016-07-20 Futura Medical Dev Ltd Topical pharmaceutical formulation
WO2019014299A1 (en) * 2017-07-11 2019-01-17 University Of Miami TOPICAL FORMULATIONS OF ACETAMINOPHENE FOR RELIEF RELIEF
DE102018101861A1 (de) * 2018-01-26 2019-08-01 Bertrand Prévôt Kosmetische oder pharmazeutische Zubereitung zur Hautpflege sowie zur Prophylaxe von Muskelkrämpfen
JP2019178110A (ja) * 2018-03-30 2019-10-17 岡山大鵬薬品株式会社 外用剤
FR3083981B1 (fr) * 2018-07-20 2021-01-15 Semiocare Sas Compositions a usage cosmetique et dermatologique
WO2020069450A1 (en) * 2018-09-28 2020-04-02 Joel Studin Transpore delivery of drugs and uses thereof
CN109125255A (zh) * 2018-09-30 2019-01-04 天津梅花生物医药科技有限公司 一种滴耳剂
AU2022271274A1 (en) * 2021-05-05 2023-11-23 Smartech Topical, Inc. Topical naproxen formulations and their use
WO2024189661A1 (en) * 2023-03-13 2024-09-19 Jordan University Of Science And Technology A topical composition comprising a ternary metal oxide nanoparticle preservative
CN116747147B (zh) * 2023-04-27 2025-10-17 南京市苗本堂健康管理有限公司 一种靶向祛痘的壬二酸微纳晶混悬液及其应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2463264A (en) * 1942-12-23 1949-03-01 Ciba Ltd Derivatives of cyclic amidines and process of making same
GB971700A (en) * 1961-02-02 1964-09-30 Boots Pure Drug Co Ltd Anti-Inflammatory Agents
US3981681A (en) * 1974-04-16 1976-09-21 Carson Products Company Depilatory formulation
US4185100A (en) * 1976-05-13 1980-01-22 Johnson & Johnson Topical anti-inflammatory drug therapy
US4049700A (en) * 1976-06-17 1977-09-20 The Upjohn Company Ibuprofen p-hydroxyphenylurea ester
CH614878A5 (enExample) * 1977-03-11 1979-12-28 Charmilles Sa Ateliers
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments
US4228163A (en) * 1979-03-30 1980-10-14 Dermik Laboratories Method for treating pseudofolliculitis barbae
FR2528420A1 (fr) * 1982-06-15 1983-12-16 Oreal Nouveaux 3-benzylidene camphres, leur procede de preparation et leur utilisation pour la protection contre les rayons uv
IL67445A (en) * 1982-12-09 1985-11-29 Teva Pharma Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
US4525344A (en) * 1983-08-15 1985-06-25 Tutsky Ronald J Skin care and shaving composition
US4525348A (en) * 1983-12-19 1985-06-25 Yoshitomi Pharmaceutical Industries, Ltd. Pranoprofen gelled ointment
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
DE3522550A1 (de) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab Aufspruehbare pharmazeutische zubereitung fuer die topische anwendung
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
WO1987002891A1 (en) * 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
DE3621036A1 (de) * 1986-06-24 1988-01-07 Merckle Gmbh Fluessige ibuprofen-zubereitungen
US4775530A (en) * 1987-01-06 1988-10-04 Perricone Nicholas V Method for treatment and prevention of pseudofolliculitis barbae
US5034221A (en) * 1989-06-22 1991-07-23 Rosen Steven E Topical agent and method for the treatment of Pseudofolliculitis barbae
US5087445A (en) * 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
US4990658B1 (en) * 1989-12-18 1994-08-30 Ethyl Corp Process for preparing ibuprofen and its alkyl esters
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5073372A (en) * 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5237071A (en) * 1991-01-22 1993-08-17 Fairmount Chemical Company, Inc. Process for preparing 2,2'-methylene-bis(6-(2H-benzotriazol-2-yl)-4-hydrocarbyl phenols)
US5166355A (en) * 1991-02-04 1992-11-24 Fairmount Chemical Co., Inc. Process for preparing substituted 2,2'-methylene-bis-[6-(2H-benzotriazol-2-yl)-4-hydrocarbyl-phenols]
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
US5315027A (en) * 1993-05-11 1994-05-24 Ethyl Corporation Catalytic process for preparing the alkyl esters of ibuprofen
US5807569A (en) * 1993-05-27 1998-09-15 Smithkline Beecham P.L.C. Topical composition
FI92454C (fi) * 1993-06-30 1994-11-25 Toivo Tammisalo Yhdistetty metsänhakkuu- ja korjuukone
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
US5643943A (en) * 1994-12-23 1997-07-01 Alcon Laboratories, Inc. Systemic administration of esters and amides of antioxidants which may be used as antioxidant prodrug therapy for oxidative and inflammatory pathogenesis
US6043232A (en) * 1997-07-23 2000-03-28 Nitromed, Inc. Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
US5750564A (en) * 1995-09-12 1998-05-12 Hellberg; Mark Anti-oxidant esters of non-steroidal anti-inflammatory agents
BR9611523A (pt) * 1995-11-13 1999-12-28 Pitmy Int Nv Meios de administração para drogas analgésicas, antiinflamatórias e antipiréticas contendo óxido nitroso e composições farmacêuticas contendo tais meios e drogas.
US6084533A (en) * 1997-02-28 2000-07-04 New Mexico State University Technology Transfer Corporation Directional traffic sensor system
US6482839B1 (en) * 1997-06-02 2002-11-19 Cellegy Pharmaceuticals, Inc. Pyridine-thiols for treatment of a follicular dermatosis
US6048533A (en) * 1997-06-30 2000-04-11 Nguyen; Van Bich Turmeric for treating health ailments
US5976566A (en) * 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin
IL127143A0 (en) * 1998-11-19 1999-09-22 Dpharm Ltd Phospholipid terivatives of non-steroidal anti inflammatory drugs
US6277362B1 (en) * 1999-10-26 2001-08-21 Isw, Inc. After shave treatment preparation
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
GB0126157D0 (en) * 2001-10-31 2002-01-02 Univ Aberdeen Therapeutic compounds
US6620813B1 (en) * 2002-06-21 2003-09-16 Medinox, Inc. Hydroxamate derivatives of non-steroidal anti-inflammatory drugs
AR036755A1 (es) * 2002-10-07 2004-09-29 Thalas Group Inc Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel
BRPI0418885A (pt) * 2004-06-07 2007-11-27 Strides Arcolab Ltd composição farmacêutica contendo uma solução estável e clara de fármaco antiinflamatória em cápsula de gelatina mole e processo para a produção da mesma
US20060067958A1 (en) * 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
JP2008531693A (ja) * 2005-03-03 2008-08-14 アイ エス ダブリュ グループ インコーポレイテッド 局所用ゲル組成物
US20070053984A1 (en) * 2005-03-03 2007-03-08 Monique Spann-Wade Topical gels compositions

Similar Documents

Publication Publication Date Title
WO2008030359A3 (en) Topical compositions
CA2864118A1 (en) Formulations of bendamustine
RU2018119295A (ru) Фармацевтические составы для местного применения для лечения связанных с воспалением состояний
JP2014505733A5 (enExample)
JP2010509292A5 (enExample)
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
BRPI0617576A2 (pt) composiÇço farmacÊutica para aplicaÇço ungueal e periungueal e uso de uma composiÇço
EP2528602A4 (en) FORMULAS FROM BENDAMUSTIN
RU2015137152A (ru) Композиции для личной гигиены
MX2015011878A (es) Compuestos aromaticos sustituidos y metodo relacionado para el tratamiento de la fibrosis.
JP2019510036A5 (enExample)
WO2010109434A3 (en) A medicinal antibacterial, antifungal and steroids cream comprising chitosan and a process to make it
JP2012521351A5 (enExample)
WO2012083138A3 (en) Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
MX2019008870A (es) Agente terapeutico para enfermedades hepaticas.
RU2013102294A (ru) Бактерицидные топические композиции
RS52620B (sr) Upotreba hitosana za lečenje inflamatornih bolesti noktiju
EP2854803B2 (fr) Compositions topiques sous forme de gel contenant un rétinoïde particulier solubilisé
AR074309A1 (es) Compuestos anti-inflamatorios y sus composiciones farmaceuticas, dentifricas y adhesivas. metodo
JP2010510194A5 (enExample)
WO2009059748A3 (en) Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations
JP2019535767A5 (enExample)
AR064263A1 (es) Composiciones farmaceuticas que comprenden un compuesto bisfosfato
IL278548B1 (en) Pharmaceutical Compositions Comprising Dronabinol and Sprays Comprising these Pharmaceutical Compositions
PE20090640A1 (es) Composicion pulverizable que contiene extracto de hojas de parra rojas